Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 1
2012 1
2013 1
2014 1
2019 1
2020 2
2021 2
2022 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Development and validation of a self-administered questionnaire measuring essential knowledge in patients with rheumatoid arthritis.
Rodère M, Pereira B, Soubrier M, Fayet F, Piperno M, Pallot-Prades B, Pouplin S, Baudens G, Cohen JD, Coquerelle P, Grange L, Sordet C, Tropé S, Gossec L, Beauvais C. Rodère M, et al. Among authors: baudens g. Rheumatol Int. 2022 Oct;42(10):1785-1795. doi: 10.1007/s00296-022-05090-8. Epub 2022 Apr 7. Rheumatol Int. 2022. PMID: 35389078 Free PMC article.
Secukinumab and ustekinumab treatment in psoriatic arthritis: results of a direct comparison.
Letarouilly JG, Flachaire B, Labadie C, Kyheng M, Cohen N, Sellam J, Richette P, Dieude P, Claudepierre P, Fautrel B, Houvenagel E, Nguyen CD, Guyot MH, Segaud N, Marguerie L, Deprez X, Salmon JH, Baudens G, Miceli-Richard C, Gervais E, Chary-Valckenaere I, Lafforgue P, Philippe P, Loeuille D, Richez C, Tubach F, Pham T, Flipo RM. Letarouilly JG, et al. Among authors: baudens g. Rheumatology (Oxford). 2021 Jun 18;60(6):2773-2782. doi: 10.1093/rheumatology/keaa710. Rheumatology (Oxford). 2021. PMID: 33232465
Differential retention of adalimumab and etanercept biosimilars compared to originator treatments: Results of a retrospective French multicenter study.
Larid G, Baudens G, Dandurand A, Coquerelle P, Goeb V, Guyot MH, Marguerie L, Maury F, Veillard E, Houvenagel E, Salmon JH, Flipo RM, Gervais E. Larid G, et al. Among authors: baudens g. Front Med (Lausanne). 2022 Oct 6;9:989514. doi: 10.3389/fmed.2022.989514. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36275803 Free PMC article.
Real-World 1-Year Retention Rate of Subcutaneous Tocilizumab Treatment in Patients with Moderate to Severe Active Rheumatoid Arthritis: TANDEM Study.
Hilliquin P, Barnetche T, Baillet A, Flipo RM, Lespessailles E, Roux C, Fardellone P, Gilbert-Marceau A, Idier I, Constantin A, Shipley E, Baudens G, Saraux A. Hilliquin P, et al. Among authors: baudens g. Rheumatol Ther. 2021 Mar;8(1):95-108. doi: 10.1007/s40744-020-00253-0. Epub 2020 Nov 20. Rheumatol Ther. 2021. PMID: 33216287 Free PMC article.
Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study.
Darloy J, Segaud N, Salmon JH, Eschard JP, Goëb V, Deprez X, Guyot MH, Houvenagel E, Lecuyer N, Marguerie L, Gally S, Pau D, Idier I, Baudens G, Flipo RM. Darloy J, et al. Among authors: baudens g. Rheumatol Ther. 2019 Mar;6(1):61-75. doi: 10.1007/s40744-018-0138-y. Epub 2019 Jan 10. Rheumatol Ther. 2019. PMID: 30632015 Free PMC article.
Low and stable prevalence of rheumatoid arthritis in northern France.
Biver E, Beague V, Verloop D, Mollet D, Lajugie D, Baudens G, Neirinck P, Flipo RM. Biver E, et al. Among authors: baudens g. Joint Bone Spine. 2009 Oct;76(5):497-500. doi: 10.1016/j.jbspin.2009.03.013. Epub 2009 Sep 19. Joint Bone Spine. 2009. PMID: 19767228